Kolexia
Lhomme Catherine Oncologie médicale
Lhomme Catherine
Oncologie médicale
Gustave-Roussy
Villejuif, France
100 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Récidive tumorale locale Carcinome épithélial de l'ovaire Tumeurs de l'endomètre Carcinomes Tumeurs du col de l'utérus Sarcomes Tumeurs épithéliales épidermoïdes et glandulaires Métastase lymphatique

Collaborateurs

Voir plus
Pautier Patricia
Pautier Patricia
Gustave-Roussy, Villejuif, France
Morice Philippe
Morice Philippe
Gustave-Roussy, Villejuif, France
Gouy Sebastien
Gouy Sebastien
Gustave-Roussy, Villejuif, France
Duvillard Pierre
Duvillard Pierre
Gustave-Roussy, Villejuif, France

Industries

Voir plus
Roche
1 collaboration(s)
Dernière en 2017
AstraZeneca
1 collaboration(s)
Dernière en 2017
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.
Gynecologic oncology   12 octobre 2020
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Annals of oncology : official journal of the European Society for Medical Oncology   12 juin 2020
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
European journal of cancer (Oxford, England : 1990)   03 juin 2019
Pooled analysis of onapristone extended release (ONA ER) in metastatic cancer patients (pts): A review of liver safety.
2019 ASCO Annual Meeting I   26 mai 2019
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
PloS one   10 octobre 2018
Determinants of severe chronic fatigue among epithelial ovarian cancer survivors: A GINECO VIVROVAIRE study.
2018 ASCO Annual Meeting I   01 juin 2018
Pattern of tumor-infiltrating lymphocytes (TILs) and PD-L1 expression in primary and metastatic epithelial ovarian cancer (EOC).
2017 ASCO-SITC Clinical Immuno-Oncology Symposium   09 avril 2018
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer.
Bulletin du cancer   29 mars 2018
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).
Annals of oncology : official journal of the European Society for Medical Oncology   21 décembre 2017
Long term quality of life among epithelial ovarian cancer patients: The GINECO case/control VIVROVAIRE Study
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017